Trials / Completed
CompletedNCT03089970
Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Exhaled breath condensate collection | Breath from humans is cooled, condensed, and collected |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2020-03-10
- Completion
- 2020-09-01
- First posted
- 2017-03-24
- Last updated
- 2021-08-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03089970. Inclusion in this directory is not an endorsement.